Skip to content
10-Q

Quarterly Report

GFR PHARMACEUTICALS INC

0001437749-11-008215

← back to feed
Filed
Nov 8, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2011 · Nov 1, 2011 42.08M sh
Shares Diluted Q3 2011 · Sep 30, 2011 42.08M sh
Shares Diluted Q3 2011 · Sep 30, 2011 42.08M sh
Shares Diluted Q3 2011 · Sep 30, 2010 42.08M sh
Shares Diluted Q3 2011 · Sep 30, 2010 42.08M sh
Stockholders Equity Q3 2011 · Sep 30, 2011 $8.18M
Stockholders Equity Q3 2011 · Dec 31, 2010 $6.36M
Current Liabilities Q3 2011 · Sep 30, 2011 $998.09K
Current Liabilities Q3 2011 · Dec 31, 2010 $1.05M
Total Liabilities Q3 2011 · Sep 30, 2011 $1.84M
Total Liabilities Q3 2011 · Dec 31, 2010 $1.86M
Current Assets Q3 2011 · Sep 30, 2011 $2.12M
Current Assets Q3 2011 · Dec 31, 2010 $1.72M
Total Assets Q3 2011 · Sep 30, 2011 $10.69M
Total Assets Q3 2011 · Dec 31, 2010 $8.82M
Capex Q3 2011 · Sep 30, 2010 $719.58K
Operating Cash Flow Q3 2011 · Sep 30, 2010 $2.29M
Cash And Equivalents Q3 2011 · Sep 30, 2010 $1.43M
Cash And Equivalents Q3 2011 · Dec 31, 2009 $55.49K
Sga Expense Q3 2011 · Sep 30, 2010 $112.27K
Sga Expense Q3 2011 · Sep 30, 2010 $378.44K
Net Income Q3 2011 · Sep 30, 2010 $671.69K
Net Income Q3 2011 · Sep 30, 2010 $1.8M
Operating Income Q3 2011 · Sep 30, 2010 $858.13K
Operating Income Q3 2011 · Sep 30, 2010 $2.12M
Gross Profit Q3 2011 · Sep 30, 2010 $1.01M
Gross Profit Q3 2011 · Sep 30, 2010 $2.64M
Cost Of Revenue Q3 2011 · Sep 30, 2010 $185.07K
Cost Of Revenue Q3 2011 · Sep 30, 2010 $535.96K